Erdosteine effect on oxidative stress, inflammatory response and immune modulation in patients with COPD. A single center, open label, double arm, controlled, 4-week, explorative, ex vivo study. (clinicaltrialsregister.eu) - May 21, 2026 - P4 | N=30 | Not yet recruiting | Sponsor: ASST Fatebenefratelli Sacco
New P4 trial • Chronic Obstructive Pulmonary Disease • Immune Modulation • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
|